Company Filing History:
Years Active: 1996
Title: The Innovations of Hans-Peter Belleman
Introduction
Hans-Peter Belleman is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of high blood pressure and atherosclerosis. His work has led to the creation of innovative pharmaceutical substances that have the potential to improve patient outcomes.
Latest Patents
One of Hans-Peter Belleman's key patents is titled "Heterocyclically substituted phenylacetic acid derivatives and their use." This invention relates to phenylacetic acid derivatives that are substituted by a five-membered nitrogen heterocycle bonded via an N atom. These compounds are synthesized through the reaction of phenylacetic acid derivatives with leaving groups and the appropriate nitrogen heterocycles. The resulting derivatives can serve as active substances in medicaments aimed at treating high blood pressure and atherosclerosis. He holds 1 patent in this area.
Career Highlights
Hans-Peter Belleman is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work has been instrumental in advancing the understanding and treatment of cardiovascular diseases.
Collaborations
Throughout his career, Hans-Peter Belleman has worked alongside esteemed colleagues such as Ulrich E Muller and Klaus Mohrs. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic agents.
Conclusion
Hans-Peter Belleman's contributions to medicinal chemistry and his innovative patent on phenylacetic acid derivatives highlight his importance in the field. His work continues to influence the development of effective treatments for serious health conditions.